142 results on '"Sebastian, Sarah"'
Search Results
2. Inceptor as a regulator of brain insulin sensitivity
3. HBV001: Phase I study evaluating the safety and immunogenicity of the therapeutic vaccine ChAdOx1-HBV
4. Chemical Composition
5. 502 Does obstructive sleep apnea in obese patients affect neonatal outcomes?
6. Potent immunogenicity and protective efficacy of a multi-pathogen vaccination targeting Ebola, Sudan, Marburg and Lassa viruse.
7. Effect of Prior ChAdOx1 COVID-19 Immunisation on T-Cell Responses to ChAdOx1-HBV †.
8. Effectiveness of an eHealth intervention for reducing psychological distress and increasing COVID-19 knowledge and protective behaviors among racialized sexual and gender minority adults: A quasi-experimental study (#SafeHandsSafeHearts).
9. Pre-Clinical Development of an Adenovirus Vector Based RSV and Shingles Vaccine Candidate
10. 665 Immunotherapeutic trial in men with biochemical recurrence after definitive local therapy for prostate cancer: A clinical trial in progress
11. ChAdOx1-vectored Lassa fever vaccine elicits a robust cellular and humoral immune response and protects guinea pigs against lethal Lassa virus challenge
12. Preclinical immunogenicity of an adenovirus-vectored vaccine for herpes zoster
13. Effectiveness of an eHealth Intervention for Reducing Psychological Distress and Increasing COVID-19 Knowledge and Protective Behaviors among Ethnoracially Diverse Sexual and Gender Minority Adults: A Quasi-experimental Study (#SafeHandsSafeHearts)
14. Development of a Molecular Adjuvant to Enhance Antigen-Specific CD8+ T Cell Responses
15. Intravenous administration of viral vectors expressing prostate cancer antigens enhances the magnitude and functionality of CD8+ T cell responses
16. Novel viral vectors in infectious diseases
17. Generation and Production of Modified Vaccinia Virus Ankara (MVA) as a Vaccine Vector
18. Revealing the voices of women living with IBD
19. The retroviral restriction factor TRIM5α
20. The Design and Development of a Multi-HBV Antigen Encoded in Chimpanzee Adenoviral and Modified Vaccinia Ankara Viral Vectors
21. Cyclophilin A is required for TRIM5[alpha]-mediated resistance to HIV-1 in Old World monkey cells
22. A Multi-Filovirus Vaccine Candidate: Co-Expression of Ebola, Sudan, and Marburg Antigens in a Single Vector
23. Preclinical Development and Assessment of Viral Vectors Expressing a Fusion Antigen of Plasmodium falciparum LSA1 and LSAP2 for Efficacy against Liver-Stage Malaria
24. A single-dose ChAdOx1-vectored vaccine provides complete protection against Nipah Bangladesh and Malaysia in Syrian golden hamsters
25. TRIM5α associates with proteasomal subunits in cells while in complex with HIV-1 virions
26. TRIM5α selectively binds a restriction-sensitive retroviral capsid
27. Novel viral vectors in infectious diseases
28. Clinical Advances in Viral-Vectored Influenza Vaccines
29. Chimpanzee adenoviral vectors as vaccines for outbreak pathogens
30. Phosphoinositide metabolism links cGMP-dependent protein kinase G to essential Ca²⁺ signals at key decision points in the life cycle of malaria parasites
31. Simian adenoviruses as vaccine vectors
32. Recombinant modified vaccinia virus Ankara-based malaria vaccines
33. Prime-boost immunotherapeutic trial in men with biochemical recurrence after definitive local therapy for prostate cancer.
34. A Plasmodium calcium-dependent protein kinase controls zygote development and transmission by translationally activating repressed mRNAs
35. A tetracycline-repressible transactivator system to study essential genes in malaria parasites
36. Recombinant modified vaccinia virus Ankara-based malaria vaccines.
37. A Tetracycline-Repressible Transactivator System to Study Essential Genes in Malaria Parasites
38. A Plasmodium Calcium-Dependent Protein Kinase Controls Zygote Development and Transmission by Translationally Activating Repressed mRNAs
39. An Invariant Surface Patch on the TRIM5α PRYSPRY Domain Is Required for Retroviral Restriction but Dispensable for Capsid Binding
40. The role of lysine 186 in HIV-1 integrase multimerization
41. Arsenic Counteracts Human Immunodeficiency Virus Type 1 Restriction by Various TRIM5 Orthologues in a Cell Type-Dependent Manner
42. TRIM5α selectively binds a restriction-sensitive retroviral capsid
43. Disruption of Human TRIM5α Antiviral Activity by Nonhuman Primate Orthologues
44. Lv1 Inhibition of Human Immunodeficiency Virus Type 1 Is Counteracted by Factors That Stimulate Synthesis or Nuclear Translocation of Viral cDNA
45. HIV-1 Vpr Induces Defects in Mitosis, Cytokinesis, Nuclear Structure, and Centrosomes
46. Phosphoinositide Metabolism Links cGMP-Dependent Protein Kinase G to Essential Ca2+ Signals at Key Decision Points in the Life Cycle of Malaria Parasites.
47. Preclinical Development and Assessment of Viral Vectors Expressing a Fusion Antigen of Plasmodium falciparumLSA1 and LSAP2 for Efficacy against Liver-Stage Malaria
48. TRIM5α selectively binds a restriction-sensitive retroviral capsid
49. The retroviral restriction factor TRIM5α
50. Generation and Production of Modified Vaccinia Virus Ankara (MVA) as a Vaccine Vector.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.